3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
165
Polycystic Ovary Syndrome
22
Neoplasm Metastasis
9
Osteoporosis
7
Neoplasms
6
Infertility
6
Endometrial Neoplasms
5
Carcinoma, Intraductal, Noninfiltrating
5
Ovarian Neoplasms
4
Breast Carcinoma In Situ
4
Arthralgia
4
Hereditary Sensory and Autonomic Neuropathies
3
Carcinoma, Ductal, Breast
3
Breast Neoplasms, Male
3
Breast Cancer Metastatic
3
Advanced Breast Cancer
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Pain
2
Leiomyoma
2
Fallopian Tube Neoplasms
2
Estrogen Receptor-positive Breast Cancer
2
Carcinoma, Lobular
2
Bone Diseases, Metabolic
2
Uterine Neoplasms
1
Patient Acceptance of Health Care
1
Ovarian Cysts
1
Osteitis Deformans
1
Obesity
1
Neoplastic Cells, Circulating
1
Interventions
Blood Specimen Collection
13
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
3
Pirinitramide
2
Morphine
2
Bevacizumab
2
ribociclib
1
lanreotide
1
jinfukang
1
eribulin
1
cabazitaxel
1
Zoledronic Acid
1
Vinorelbine
1
Trastuzumab
1
Thiotepa
1
Taxes
1
Stem Cell Transplantation
1
Standard of Care
1
Spinal Puncture
1
Sorafenib
1
Radiofrequency Ablation
1
Propofol
1
Pemetrexed
1
Octreotide
1
Letrozole
1
Lapatinib
1
Injections, Epidural
1
Injections
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplastic Cells, Circulating
×
Letrozole
×
Clear all
NCT02958852
2025-09-10
ABC-SE
Lund University Hospital
Phase 2
Completed
126 enrolled